Live from the NIH registry
Studies recruiting near Gastonia right now
Top 25 of 644 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Novant Health Presbyterian Medical Center — Charlotte, North Carolina (19.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluation of the Pathobiology of CALR-mutated MPN Cells
Myeloproliferative Neoplasm
N/A
Observational 35 participants sought
Atrium Health Levine Cancer — Charlotte, North Carolina (19.4 mi)
· Sponsor: Wake Forest University Health Sciences
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Charlotte, North Carolina (19.4 mi)
· Sponsor: Sameek Roychowdhury
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Huntersville, North Carolina (22.3 mi)
· Sponsor: Dren Bio
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Carolina Oncology Specialists, PA ( Site 9002) — Charlotte, North Carolina (19.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Phase 3
Interventional 641 participants sought
Levine Cancer Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: Janssen Research & Development, LLC
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Levine Cancer Institute-Gaston — Gastonia, North Carolina (0.9 mi)
· Sponsor: NRG Oncology
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Novant Health Presbyterian Medical Center ( Site 0177) — Charlotte, North Carolina (19.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Charlotte, North Carolina (19.4 mi)
· Sponsor: AstraZeneca
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Levine Cancer Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: Eli Lilly and Company
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Levine Children's Hospital — Charlotte, North Carolina (19.4 mi)
· Sponsor: Giselle Sholler
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10318, Charlotte, NC — Charlotte, North Carolina (19.4 mi)
· Sponsor: Colorado Prevention Center
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Colitis, Ulcerative
N/A
Observational 300 participants sought
OnSite Clinical Solutions, LLC — Charlotte, North Carolina (19.4 mi)
· Sponsor: Pfizer
Daoist Zhanzhuang and Human Flourishing
Stress, Physiological, Stress, Psychological
N/A
Interventional 120 participants sought
University of North Carolina at Charlotte — Charlotte, North Carolina (19.4 mi)
· Sponsor: University of North Carolina, Charlotte
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
Acute Myeloid Leukemia
N/A
Interventional 120 participants sought
Levine Cancer Insitute — Charlotte, North Carolina (19.4 mi)
· Sponsor: Wake Forest University Health Sciences
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
DelRicht Research — Charlotte, North Carolina (19.4 mi)
· Sponsor: Crystalys Therapeutics
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
Carolinas Health System — Charlotte, North Carolina (19.4 mi)
· Sponsor: Edwards Lifesciences
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Charlotte, North Carolina (19.4 mi)
· Sponsor: AstraZeneca
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Novant Health Clinical Research/Heart & Vascular Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: Duke University
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Charlotte, North Carolina (19.4 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
PREcision MEDicine In Achalasia (PREMEDIA)
Type I Achalasia, Type II Achalasia
Phase 3
Interventional 372 participants sought
Atrium Health/Wake Forest — Charlotte, North Carolina (19.4 mi)
· Sponsor: Northwestern University
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Atrium Health Levine Cancer Proton & Advanced Radiation Center — Charlotte, North Carolina (19.4 mi)
· Sponsor: Proton Collaborative Group
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Multiple conditions
Phase 1
Interventional 46 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (19.4 mi)
· Sponsor: National Cancer Institute (NCI)